CN Patent

CN116457344A — 低分子量蛋白质降解剂及其应用

Assigned to Captor Therapeutics SA · Expires 2023-07-18 · 3y expired

What this patent protects

本发明涉及式(Ia)、(Ib)、(Ic)和(II)的化合物及其在治疗癌症的方法中的用途。这些化合物可以与现有的抗癌疗法联合使用，以提高其疗效。

USPTO Abstract

本发明涉及式(Ia)、(Ib)、(Ic)和(II)的化合物及其在治疗癌症的方法中的用途。这些化合物可以与现有的抗癌疗法联合使用，以提高其疗效。

Drugs covered by this patent

belumosudil-mesylate (BELUMOSUDIL MESYLATE)

Patent Metadata

Patent number: CN116457344A
Jurisdiction: CN
Classification: —
Expires: 2023-07-18
Drug substance claim: No
Drug product claim: No
Assignee: Captor Therapeutics SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.